Publications by authors named "B Buldini"

Claim this Profile
R
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.
Hanna Gottschalk, Anja Möricke, Valentino Conter, Martin Schrappe, Jan Starý, Barbara Buldini

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF -TD to Venetoclax/Azacitidine.
Pietro Merli, Riccardo Masetti, Martina Pigazzi, Katia Girardi, Evelina Miele, Barbara Buldini

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway.
Giulia Veltri, Alberto Peloso, Alice Cani, Elena Mariotto, Diana Corallo, Barbara Buldini

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel.
C Michel Zwaan, Sarah K Tasian, Richard Aplenc, Lisa Eidenschink Brodersen, Barbara Buldini

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy.
Gunnar Cario, Maria Grazia Valsecchi, Valentino Conter, Giacomo Gotti, Anja Möricke, Barbara Buldini

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis